Rondo TherapeuticsRegistry sponsor categoryIndustryclinicaltrials.govNames and classificationOther namesRondo TherapeuticsCompany nameRondo TherapeuticsOrganisation typeIndustryRegistry sponsor categoryIndustryclinicaltrials.govLocation and listingPublicly traded (proxy)NoListing at sourceListedRelated recordsTrials (1)A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4